midostaurin 25 MG Oral Capsule

RxCUI: 1919088
RxNorm name: midostaurin 25 MG Oral Capsule
Display name: midostaurin 25 MG Oral Capsule
Full name: midostaurin 25 MG Oral Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
RYDAPT	RYDAPT	Novartis Pharmaceuticals Corporation	11fa3fc9-6776-49a6-b1c1-653f627c3e58	2026-06-08	Warnings, Adverse reactions	Exact identifier rxcui: 1919088

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
11fa3fc9-6776-49a6-b1c1-653f627c3e58	midostaurin 25 MG Oral Capsule	PSN	14	These highlights do not include all the information needed to use RYDAPT safely and effectively. See full prescribing information for RYDAPT. RYDAPT ® (midostaurin) capsules, for oral use Initial U.S. Approval: 2017	20250618
11fa3fc9-6776-49a6-b1c1-653f627c3e58	midostaurin 25 MG Oral Capsule	SCD	14	These highlights do not include all the information needed to use RYDAPT safely and effectively. See full prescribing information for RYDAPT. RYDAPT ® (midostaurin) capsules, for oral use Initial U.S. Approval: 2017	20250618